Volver a Agenda
Session Chair(s)
Qi Jiang, PHD
Executive Director, Global Biostatistical Science
Amgen Inc., United States
Learning Objective : Discuss the key existing benefit-risk methods; List recommended methods from statisticians in the Quantitative Sciences in Pharmaceutical Industry (QSPI) Benefit-Risk Working Group; Describe best practice sharing on benefit-risk assessment implementation.
Speaker(s)
Structured Benefit-Risk Assessment Across the Life Cycle of Products: Methods, Examples and Challenges
George Quartey, PHD, MSC
Genentech, A Member of the Roche Group, United States
Scientific Enablement Leader
Current Benefit-Risk Practice: What Has Resonated, What Has Not?
Andreas Sashegyi, PHD
Eli Lilly and Company, United States
Senior Research Advisor, Statistics
Uncertainty in Benefit-Risk Assessment
Qi Jiang, PHD
Amgen Inc., United States
Executive Director, Global Biostatistical Science
¿Tiene una cuenta?